Medicofarma Biotech (WAR:MDB) Non Operating Income: zł0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:MDB Medicofarma Biotech SA WAR:MDB
35 GF Score
Price zł0.39
GF Value zł0.12
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Medicofarma Biotech Non Operating Income?

Medicofarma Biotech WAR:MDB -1.03% 35 Non Operating Income is zł0.00 Mil as of Jun. 2026. GuruFocus rates WAR:MDB with a GF Score™ of 35/100 and a GF Value™ of zł0.12 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Medicofarma Biotech's Non Operating Income for the three months ended in Jun. 2026 was zł0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was zł0.00 Mil.

Medicofarma Biotech Non Operating Income Related Terms

Medicofarma Biotech Non Operating Income Historical Data

* Premium members only.

The historical data trend for Medicofarma Biotech's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicofarma Biotech Non Operating Income Chart

Medicofarma Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medicofarma Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:MDB
35GF Score
Medicofarma Biotech SA WAR:MDB
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicofarma Biotech Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of zł0.00 Mil mean?
Medicofarma Biotech (WAR:MDB) has a Non Operating Income of zł0.00 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Medicofarma Biotech and its competitors.
Is Medicofarma Biotech's Non Operating Income too high?
Medicofarma Biotech's current Non Operating Income is zł0.00 Mil. Overall, Medicofarma Biotech has a GF Score™ of 35/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medicofarma Biotech's Non Operating Income compare to ZTS and UTHR?
Medicofarma Biotech's Non Operating Income of zł0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Drug Manufacturers company?
A good Non Operating Income depends on the Drug Manufacturers industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Medicofarma Biotech and its competitors. Medicofarma Biotech's current Non Operating Income is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicofarma Biotech stock overvalued right now?
Based on GuruFocus' analysis, Medicofarma Biotech (WAR:MDB) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.12, compared to a current price of zł0.39 — trading 221.7% above its estimated fair value. The current Non Operating Income is zł0.00 Mil. Medicofarma Biotech's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Medicofarma Biotech (WAR:MDB), the current Non Operating Income is zł0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicofarma Biotech (WAR:MDB) Overvalued in 2026?

Based on GuruFocus' analysis, Medicofarma Biotech stock appears to be overvalued. The current stock price of zł0.39 is trading 221.7% above its estimated GF Value™ of zł0.12. GuruFocus considers Medicofarma Biotech to be Significantly Overvalued.

Key valuation signals for WAR:MDB:

  • Non Operating Income: zł0.00 Mil
  • GF Value™: zł0.12 vs. price of zł0.39 (221.7% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the WAR:MDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicofarma Biotech Business Description

Address ul. Sokołowska 9 lok. U19, Warsaw, POL, 01-142
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.
35GF Score

Get the complete analysis for WAR:MDB

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.39
Price
zł0.12
GF Value